MicroRNA Childhood Cancer Catalog (M3Cs)

Publication Title	DOI	Year
Modulation of chemotherapeutic drug resistance in neuroblastoma SK-N-AS cells by the neural apoptosis inhibitory protein and miR-520f	https://doi.org/10.1002/ijc.29144	2015	Cell line 1 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
miRNA-584-5p exerts tumor suppressive functions in human neuroblastoma through repressing transcription of matrix metalloproteinase 14	https://doi.org/10.1016/j.bbadis.2015.06.002	2015	Cell line 3 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 1 Master/Detail View
miR-204 mediates post-transcriptional down-regulation of PHOX2B gene expression in neuroblastoma cells	https://doi.org/10.1016/j.bbagrm.2015.06.008	2015	Cell line 1 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
A LIN28B-RAN-AURKA Signaling Network Promotes Neuroblastoma Tumorigenesis	https://doi.org/10.1016/j.ccell.2015.09.012	2015	Cell line 1 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
miR-362-5p inhibits proliferation and migration of neuroblastoma cells by targeting phosphatidylinositol 3-kinase-C2?	https://doi.org/10.1016/j.febslet.2015.05.056	2015	Cell line 2 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 1 Master/Detail View
High-throughput microRNA profiling of pediatric high-grade gliomas.	https://doi.org/10.1093/neuonc/not215	2014	Cell line 6 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 6 Master/Detail View
Triptolide inhibits the proliferation and migration of medulloblastoma Daoy cells by upregulation of microRNA-138.	https://doi.org/10.1002/jcb.27307	2018	Cell line 0 Master/Detail View	Cell line and drug 1 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
A novel small molecular STAT3 inhibitor, LY5, inhibits cell viability, cell migration, and angiogenesis in medulloblastoma cells.	https://doi.org/10.1074/jbc.M114.616748	2014	Cell line 0 Master/Detail View	Cell line and drug 1 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
Ginsenoside Rh2 inhibits proliferation and migration of medulloblastoma Daoy by down-regulation of microRNA-31.	https://doi.org/10.1002/jcb.26716	2018	Cell line 0 Master/Detail View	Cell line and drug 1 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
Downregulation of SUN2, a novel tumor suppressor, mediates miR-221/222-induced malignancy in central nervous system embryonal tumors.	https://doi.org/10.1093/carcin/bgu105	2014	Cell line 6 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 6 Master/Detail View
Targeting MYCN IRES in MYCN-amplified neuroblastoma with miR-375 inhibits tumor growth and sensitizes tumor cells to radiation	https://doi.org/10.1016/j.molonc.2015.03.005	2015	Cell line 2 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
Downregulation of miR-137 and miR-6500-3p promotes cell proliferation in pediatric high-grade gliomas	https://doi.org/10.18632/oncotarget.7736	2016	Cell line 5 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 2 Master/Detail View
Deregulation of focal adhesion pathway mediated by miR-659-3p is implicated in bone marrow infiltration of stage M neuroblastoma patients	https://doi.org/10.18632/oncotarget.3745	2015	Cell line 2 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 1 Master/Detail View
Genome wide expression profiling of p53 regulated miRNAs in neuroblastoma	https://doi.org/10.1038/srep09027	2015	Cell line 5 Master/Detail View	Cell line and drug 5 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
MicroRNA 128a increases intracellular ROS level by targeting Bmi-1 and inhibits medulloblastoma cancer cell growth by promoting senescence.	https://doi.org/10.1371/journal.pone.0010748	2010	Cell line 3 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
Etoposide-resistance in a neuroblastoma model cell line is associated with 13q14.3 mono-allelic deletion and miRNA-15a/16-1 down-regulation	https://doi.org/10.1038/s41598-018-32195-7	2018	Cell line 0 Master/Detail View	Cell line and drug 2 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
miR-129 inhibits tumor growth and potentiates chemosensitivity of neuroblastoma by targeting MYO10	https://doi.org/10.1016/j.biopha.2018.04.153	2018	Cell line 2 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 1 Master/Detail View
Indirect Down-regulation of Tumor-suppressive let-7 Family MicroRNAs by LMO1 in Neuroblastoma	https://doi.org/10.21873/cgp.20100	2018	Cell line 11 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
MicroRNA-664a-5p promotes neuronal differentiation of SH-SY5Y cells	https://doi.org/10.1111/gtc.12559	2018	Cell line 1 Master/Detail View	Cell line and drug 1 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
MicroRNA-1247 inhibits cell proliferation by directly targeting ZNF346 in childhood neuroblastoma	https://doi.org/10.1186/s40659-018-0162-y	2018	Cell line 2 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View

Publications